This is the authors' abstract. We don't add key points for this paper.
Glycated haemoglobin (HbA1c) is used in diagnosis & monitoring of diabetes mellitus & was found to be affected by many factors other than blood glucose; iron deficiency anemia is one of them. In our study 50 patients of iron deficiency anemia were included. All were non-diabetic based on fasting blood sugar (FBS), post prandial blood sugar (PPBS) level & history. HbA1c level, serum ferritin & iron level were calculated before & after 6 months of iron replacement. It was found that after iron therapy HbA1c level was significantly decreased & serum ferritin & serum iron level were significantly increased. Serum ferritin & iron level were negatively correlated to HbA1c before therapy & after that serum iron was positively correlated but serum ferritin remained negatively correlated to HbA1c level. Importantly FBS before & after treatment remained significantly positively correlated as was PPBS. HbA1c level was reduced with iron replacement in iron deficiency anemia independent of blood sugar.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Dadarwal et al. (2017) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: